These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

511 related articles for article (PubMed ID: 19447084)

  • 1. Evaluation of the effectiveness of botulinum toxin injections in the lower limb muscles of children with cerebral palsy. Preliminary prospective study of the advantages of ultrasound guidance.
    Py AG; Zein Addeen G; Perrier Y; Carlier RY; Picard A
    Ann Phys Rehabil Med; 2009 Apr; 52(3):215-23. PubMed ID: 19447084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Botulinum A in the treatment of equinus dynamic spasticity in children with cerebral palsy. Preliminary study].
    Mousny M; Allington N
    Rev Chir Orthop Reparatrice Appar Mot; 1999 May; 85(2):156-63. PubMed ID: 10392416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective study examining remote effects of botulinum toxin a in children with cerebral palsy.
    Crowner BE; Racette BA
    Pediatr Neurol; 2008 Oct; 39(4):253-8. PubMed ID: 18805363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parotid and submandibular botulinum toxin A injections for sialorrhoea in children with cerebral palsy.
    Banerjee KJ; Glasson C; O'Flaherty SJ
    Dev Med Child Neurol; 2006 Nov; 48(11):883-7. PubMed ID: 17044954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional outcome of botulinum toxin injection of gastrocnemius and adductors in spastic hemiplegic cerebral palsied children.
    Ibrahim AI; Hawamdeh ZM; Al-Qudah AA
    Eura Medicophys; 2007 Mar; 43(1):13-20. PubMed ID: 17021584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upper limb function after botulinum toxin A treatment in cerebral palsy: two years follow-up of six cases.
    Sätilä H; Kotamäki A; Koivikko M; Autti-Rämö I
    Pediatr Rehabil; 2006; 9(3):247-58. PubMed ID: 17050402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Botulinum A toxin for treatment of lower limb spasticity in cerebral palsy: gait analysis in 49 patients.
    Papadonikolakis AS; Vekris MD; Korompilias AV; Kostas JP; Ristanis SE; Soucacos PN
    Acta Orthop Scand; 2003 Dec; 74(6):749-55. PubMed ID: 14763710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term effects of botulinum toxin A in children with cerebral palsy.
    Tedroff K; Granath F; Forssberg H; Haglund-Akerlind Y
    Dev Med Child Neurol; 2009 Feb; 51(2):120-7. PubMed ID: 19191845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Botulinum toxin (Dysport) treatment of the spastic gastrocnemius muscle in children with cerebral palsy: a randomized trial comparing two injection volumes.
    Hu GC; Chuang YC; Liu JP; Chien KL; Chen YM; Chen YF
    Clin Rehabil; 2009 Jan; 23(1):64-71. PubMed ID: 19114438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultrasound-guided submandibular gland injection of botulinum toxin for hypersalivation in cerebral palsy.
    Sriskandan N; Moody A; Howlett DC
    Br J Oral Maxillofac Surg; 2010 Jan; 48(1):58-60. PubMed ID: 19371986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term effect of botulinum toxin (A) in the management of calf spasticity in children with diplegic cerebral palsy.
    Hawamdeh ZM; Ibrahim AI; Al-Qudah AA
    Eura Medicophys; 2007 Sep; 43(3):311-8. PubMed ID: 17268388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of botulinum toxin in the treatment of lower limb spasticity in children with cerebral palsy--a pilot study.
    Zelnik N; Giladi N; Goikhman I; Keren G; Moris R; Honigman S
    Isr J Med Sci; 1997 Feb; 33(2):129-33. PubMed ID: 9254875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose/high-concentration localized botulinum toxin A improves upper limb movement and function in children with hemiplegic cerebral palsy.
    Lowe K; Novak I; Cusick A
    Dev Med Child Neurol; 2006 Mar; 48(3):170-5. PubMed ID: 16483391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Botulinum toxin type A injections can be an effective treatment for pain in children with hip spasms and cerebral palsy.
    Lundy CT; Doherty GM; Fairhurst CB
    Dev Med Child Neurol; 2009 Sep; 51(9):705-10. PubMed ID: 19459910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Botulinum toxin as a treatment for infantile cerebral palsy].
    Pascual-Pascual SI; Sánchez de Muniain P; Roche MC; Pascual-Castroviejo I
    Rev Neurol; 1997 Sep; 25(145):1369-75. PubMed ID: 9377292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Botulinum toxin-a in children with congenital spastic hemiplegia does not improve upper extremity motor-related function over rehabilitation alone: a randomized controlled trial.
    Rameckers EA; Speth LA; Duysens J; Vles JS; Smits-Engelsman BC
    Neurorehabil Neural Repair; 2009; 23(3):218-25. PubMed ID: 19106252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term efficacy and tolerability of 4-monthly versus yearly botulinum toxin type A treatment for lower-limb spasticity in children with cerebral palsy.
    Kanovský P; Bares M; Severa S; Richardson A;
    Dev Med Child Neurol; 2009 Jun; 51(6):436-45. PubMed ID: 19563586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Botulinum toxin A in the management of spastic gait disorders in children and young adults with cerebral palsy: a randomized, double-blind study of "high-dose" versus "low-dose" treatment.
    Wissel J; Heinen F; Schenkel A; Doll B; Ebersbach G; Müller J; Poewe W
    Neuropediatrics; 1999 Jun; 30(3):120-4. PubMed ID: 10480205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of multilevel botulinum toxin a and comprehensive rehabilitation on gait in cerebral palsy.
    Scholtes VA; Dallmeijer AJ; Knol DL; Speth LA; Maathuis CG; Jongerius PH; Becher JG
    Pediatr Neurol; 2007 Jan; 36(1):30-9. PubMed ID: 17162194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Botulinum A toxin urethral sphincter injection in children with nonneurogenic neurogenic bladder.
    Mokhless I; Gaafar S; Fouda K; Shafik M; Assem A
    J Urol; 2006 Oct; 176(4 Pt 2):1767-70; discussion 1770. PubMed ID: 16945643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.